share_log

CORRESP: CORRESP

SEC announcement ·  Apr 23 01:23
Summary by Futu AI
Apollomics Inc., a biopharmaceutical company, has submitted a request to the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The request, filed on April 22, 2024, seeks to have the Registration Statement declared effective at 5:00 p.m. Washington, D.C. time on April 24, 2024, or as soon as possible thereafter. This filing follows the initial submission of the Registration Statement on April 1, 2024. Apollomics has engaged Daniel Nussen of White & Case LLP to handle any inquiries and to be notified upon the approval of the acceleration request.
Apollomics Inc., a biopharmaceutical company, has submitted a request to the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form F-3. The request, filed on April 22, 2024, seeks to have the Registration Statement declared effective at 5:00 p.m. Washington, D.C. time on April 24, 2024, or as soon as possible thereafter. This filing follows the initial submission of the Registration Statement on April 1, 2024. Apollomics has engaged Daniel Nussen of White & Case LLP to handle any inquiries and to be notified upon the approval of the acceleration request.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.